Literature DB >> 7130855

Compartmentalization of phosphatidylethanolamine in microsomal membranes from rat liver.

C Valtersson, G Dallner.   

Abstract

Microsomal membranes from rat liver were treated with the cross-linking reagent 1,5-difluoro-2,4-dinitrobenzene (DFDNB). Experimental work showed that at a probe concentration of 0.75 mM all free phosphatidylethanolamine (PE) and phosphatidylserine (PS) were found as dinitrophenyl derivatives: 29% of PE was in monomeric form, 9% dimeric, 2% interacted with PS, and 63% cross-linked to protein. PS showed a greater percent in monomeric and dimeric form and only 31% was cross-linked to protein. The cross-linking pattern of PE was clearly different from that pattern which is present in the inner mitochondrial and erythrocyte membranes. In vivo labeling of PE with [(3)H]glycerol and [(3)H]ethanolamine followed by phospholipase A(2) treatment of isolated microsomes established a heterogeneous labeling pattern during the first 2 hours. During this period, the specific activity of the phospholipase A(2)-sensitive compartment was considerably higher. The differential distribution of radioactivity after in vivo labeling in the part of the PE which reacted with increasing concentrations of DFDNB also indicated compartmentalization. After in vivo labeling with the precursors, the time course of the specific radioactivity demonstrated an initial high labeling, almost exclusively in the monomeric form, followed by a later appearance of the label in the protein-bound PE. The experiments indicate that the biosynthesis of PE takes place in a compartment that is more accessible to surface probes and that the labeled molecules are transferred in a time-dependent process to a second compartment where the lipid is not available for phospholipase A(2) action but is available for cross-linking to protein.-Valtersson, C., and G. Dallner. Compartmentalization of phosphatidylethanolamine in microsomal membranes from rat liver.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130855

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

Review 1.  The assembly of lipids into lipoproteins during secretion.

Authors:  J E Vance; D E Vance
Journal:  Experientia       Date:  1990-06-15

2.  Compartmentation of newly synthesized phosphatidylethanolamine in rat brain microsomes.

Authors:  L Binaglia; R Roberti; L Freysz; G Arienti; L Corazzi; G Porcellati
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

3.  Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas.

Authors:  I Eggens; T J Ekström; F Aberg
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

4.  The lipid composition of highly differentiated human hepatomas, with special reference to fatty acids.

Authors:  I Eggens; L Bäckman; A Jakobsson; C Valtersson
Journal:  Br J Exp Pathol       Date:  1988-10

5.  Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.

Authors:  M Söderberg; C Edlund; K Kristensson; G Dallner
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

6.  Effect of dietary fat on rat liver microsomal and mitochondrial/lysosomal dolichol, phospholipid and cholesterol.

Authors:  A Jakobsson-Borin; O Tollbom; G Dallner
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

7.  Age-related changes in the lipid compositions of rat and human tissues.

Authors:  A Kalén; E L Appelkvist; G Dallner
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

8.  Dolichol and dolichyl phosphate in human tissues.

Authors:  O Tollbom; G Dallner
Journal:  Br J Exp Pathol       Date:  1986-10

9.  Phospholipid distribution in the cytoplasmic membrane of Gram-negative bacteria is highly asymmetric, dynamic, and cell shape-dependent.

Authors:  Mikhail Bogdanov; Kyrylo Pyrshev; Semen Yesylevskyy; Sergey Ryabichko; Vitalii Boiko; Pavlo Ivanchenko; Ramziya Kiyamova; Ziqiang Guan; Christophe Ramseyer; William Dowhan
Journal:  Sci Adv       Date:  2020-06-03       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.